Letermovir
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Letermovir and local guidelines before prescribing.
Antiviral (CMV)
Mechanism
CMV terminase complex inhibitor.
Uses
CMV prophylaxis after stem-cell or kidney transplant.
Dosing
No dose is given in the chapters. See the BNF.
Side effects
Nausea, diarrhoea, peripheral oedema.
Interactions
Ciclosporin raises levels; many CYP interactions.
Contraindications and cautions
Co-administration with pimozide
Monitoring
CMV load
Pregnancy and breastfeeding
Avoid
Renal and hepatic impairment
Caution in severe renal impairment
Overdose and reversal
Supportive
Special advice
Prophylaxis only.
More from the textbook: uses, cautions and other points
- CMV drugs - ganciclovir (IV) and valganciclovir (oral) - marrow suppression , teratogenic (handle with care); foscarnet - kidney toxicity, low calcium, magnesium and potassium; letermovir (prophylaxis after stem cell transplant), maribavir (resistant CMV).
ID: How Infection Happens - Transplant recipients - CMV viraemia, pneumonitis, hepatitis, colitis, graft dysfunction; managed by regular CMV PCR monitoring with pre-emptive treatment, or prophylaxis (valganciclovir, letermovir).
ID: Viral, fungal and parasitic infections - Letermovir | CMV prophylaxis after stem cell transplant.
ID: Viral, fungal and parasitic infections - Antiviral - aciclovir or valaciclovir (HSV and VZV) in stem cell transplant, bortezomib and some chemotherapy; valganciclovir or letermovir (CMV) after transplant; HBV prophylaxis with rituximab if anti-HBc positive.
Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination - Prophylaxis - co-trimoxazole (PCP), valganciclovir (CMV - 3–6 months) or letermovir, or pre-emptive CMV PCR monitoring; antifungals in some.
Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology - CMV | Usually asymptomatic or glandular-fever-like | Congenital CMV (commonest congenital infection - sensorineural deafness, microcephaly, chorioretinitis); transplant and HIV (retinitis, colitis, pneumonitis) | Ganciclovir/valganciclovir; letermovir prophylaxis after stem cell transplant
Microbiology: Virology - structure, replication and important viral infections
Where it is discussed in the book
- ID: How Infection Happens (1 mention)
- ID: Viral, fungal and parasitic infections (2 mentions)
- Clinical Immunology: Secondary immunodeficiency, the immunocompromised host and vaccination (1 mention)
- Clinical Immunology: Biologics, immunotherapy, checkpoint toxicity and transplant immunology (1 mention)
- Microbiology: Virology - structure, replication and important viral infections (1 mention)